share_log

8-K: Current report

SEC ·  Jun 28 20:37

Summary by Futu AI

On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.
On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.